Sartorius presents new premium mechanical pipette Tacta
Responding to the needs of users in the laboratories, Sartorius presents a new range of mechanical pipettes with a perfectly balanced design offering reliability, accuracy and comfortable use.
Now available from Sartorius, the Tacta range of premium mechanical pipettes. Tacta has perfectly balanced design that it is easy, safe and comfortable to use. Tacta meets the most demanding pipetting requirements, delivering consistent and accurate results time after time. Manufactured from carefully selected materials, each component is designed to meet the highest standards of comfort and reliability. The new pipettes are available in a range of volumes from 0.1 to 10,000 µL in single channel models, and from 0.5 to 300 µL in multichannel models.
Tacta’s ergonomic and clever design enables extremely low pipetting and tip ejection forces that reduce the risk of Work Related Upper Limb Disorder (WRULD). The unique handle and finger hook design let the pipette rest lightly in the user’s hand, with no need to grip the handle tightly, providing reliable and accurate results during lengthy pipetting sessions. The new Sartorius Optiject, levered tip ejection technology, enables controlled and smooth tip ejection with minimum force. The Optiload feature, with spring-loaded tip cones in both single and multi-channel models, ensures tip loading with perfect sealing and minimal force.
In addition, the new Sartorius Optilock system provides flexible volume adjustment and locking functionalities, and prevents accidental volume changes during pipetting. Tacta has a large, clear 4-digit display, which makes the volume easy to read even when the pipette is at an angle. Furthermore, Tacta is very easy to adjust for a variety of liquids, using a simple adjustment key. An integrated adjustment functionality and scale show the degree of adjustment and, by noting this value for a specific liquid, the user can return to that setting any time.
With only three parts to disassemble and requiring no tools, Tacta pipettes are particularly quick and easy to clean. They can also be autoclaved without disassembly and are highly resistant to exposure to UV and chemicals. In addition, Safe-Cone Filters are available for all Tacta models with volumes of more than 10 µL and offer a cost-effective method to reduce contamination. The unique Safe-Cone Filter ejector enables easy removal of used or contaminated filters without human contact. All Tacta pipettes are fully compatible with original Sartorius “Optifit” and “SafetySpace” pipette tips, enabling maximum accuracy and precision.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance